Schoenberg Mark sold URGN
September 8, 2026 · Form 4 insider transaction
Schoenberg Mark sold 871 shares of UroGen Pharma Ltd. at $42.92 per share, a transaction worth $37.4K. The trade was recorded as open-market sale and disclosed on an SEC Form 4, filed 1 day after the transaction.
Direction
Disposed (sell-side)
Shares
871
Price
$42.92
Total value
$37.4K
InsiderSchoenberg Mark
Role—
CompanyUroGen Pharma Ltd. (URGN)
SecurityOrdinary Shares
Transaction codeS: Open-market sale
Transaction dateSeptember 8, 2026
Filing dateSeptember 9, 2026
Shares owned after59,882
OwnershipDirect
10b5-1 planNo
AmendedNo
Footnotes
Represents shares sold to satisfy withholding tax obligations upon the settlement of restricted stock units.